At the time of writing, Alaunos Therapeutics Inc [TCRT] stock is trading at $2.13, up 1.43%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The TCRT shares have gain 20.34% over the last week, with a monthly amount drifted -25.26%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
For the past year, the stock price of Alaunos Therapeutics Inc fluctuated between $1.31 and $6.20. Alaunos Therapeutics Inc [NASDAQ: TCRT] shares were valued at $2.13 at the most recent close of the market.
Analyzing the TCRT fundamentals
According to Alaunos Therapeutics Inc [NASDAQ:TCRT], the company’s sales were 0.01M for trailing twelve months, which represents an -100.00% plunge. Gross Profit Margin for this corporation currently stands at 1.67% with Operating Profit Margin at -672.67%, Pretax Profit Margin comes in at -665.5%, and Net Profit Margin reading is -665.5%. To continue investigating profitability, this company’s Return on Assets is posted at -0.84, Equity is -1.68 and Total Capital is -1.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.02 points at the first support level, and at 1.92 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.27, and for the 2nd resistance point, it is at 2.42.
Ratios To Look Out For
It is important to note that Alaunos Therapeutics Inc [NASDAQ:TCRT] has a current ratio of 3.48. Further, the Quick Ratio stands at 3.48, while the Cash Ratio is 2.68. Considering the valuation of this stock, the price to sales ratio is 470.00, the price to book ratio is 1.21.
Transactions by insiders
Recent insider trading involved Vieser Jaime, Director, that happened on Dec 31 ’24 when 3000.0 shares were sold. Director, Vieser Jaime completed a deal on Dec 31 ’24 to buy 3000.0 shares.
